Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Assets (2018 - 2025)

TELA Bio has reported Assets over the past 8 years, most recently at $81.4 million for Q4 2025.

  • Quarterly results put Assets at $81.4 million for Q4 2025, down 5.95% from a year ago — trailing twelve months through Dec 2025 was $81.4 million (down 5.95% YoY), and the annual figure for FY2025 was $81.4 million, down 5.95%.
  • Assets for Q4 2025 was $81.4 million at TELA Bio, up from $61.6 million in the prior quarter.
  • Over the last five years, Assets for TELA hit a ceiling of $94.4 million in Q2 2023 and a floor of $51.3 million in Q2 2022.
  • Median Assets over the past 5 years was $70.3 million (2021), compared with a mean of $70.8 million.
  • Biggest five-year swings in Assets: surged 83.87% in 2023 and later tumbled 39.28% in 2024.
  • TELA Bio's Assets stood at $62.5 million in 2021, then increased by 8.49% to $67.9 million in 2022, then rose by 15.02% to $78.0 million in 2023, then increased by 10.92% to $86.6 million in 2024, then fell by 5.95% to $81.4 million in 2025.
  • The last three reported values for Assets were $81.4 million (Q4 2025), $61.6 million (Q3 2025), and $67.5 million (Q2 2025) per Business Quant data.